These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22226460)

  • 1. Quality by Design: Multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation.
    Monks K; Molnár I; Rieger HJ; Bogáti B; Szabó E
    J Chromatogr A; 2012 Apr; 1232():218-30. PubMed ID: 22226460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of the "Design Space" in high pressure liquid chromatography method development.
    Molnár I; Rieger HJ; Monks KE
    J Chromatogr A; 2010 May; 1217(19):3193-200. PubMed ID: 20189187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the term "Design Space" in high performance liquid chromatography (I).
    Monks KE; Rieger HJ; Molnár I
    J Pharm Biomed Anal; 2011 Dec; 56(5):874-9. PubMed ID: 21893394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico robustness testing of a compendial HPLC purity method by using of a multidimensional design space build by chromatography modeling-Case study pramipexole.
    Schmidt AH; Stanic M; Molnár I
    J Pharm Biomed Anal; 2014 Mar; 91():97-107. PubMed ID: 24440825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid high performance liquid chromatography method development with high prediction accuracy, using 5cm long narrow bore columns packed with sub-2microm particles and Design Space computer modeling.
    Fekete S; Fekete J; Molnár I; Ganzler K
    J Chromatogr A; 2009 Nov; 1216(45):7816-23. PubMed ID: 19815221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring better column selectivity choices in ultra-high performance liquid chromatography using quality by design principles.
    Kormány R; Molnár I; Rieger HJ
    J Pharm Biomed Anal; 2013 Jun; 80():79-88. PubMed ID: 23528332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A stepwise strategy employing automated screening and DryLab modeling for the development of robust methods for challenging high performance liquid chromatography separations: a case study.
    Jayaraman K; Alexander AJ; Hu Y; Tomasella FP
    Anal Chim Acta; 2011 Jun; 696(1-2):116-24. PubMed ID: 21621040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space.
    Debrus B; Lebrun P; Kindenge JM; Lecomte F; Ceccato A; Caliaro G; Mbay JM; Boulanger B; Marini RD; Rozet E; Hubert P
    J Chromatogr A; 2011 Aug; 1218(31):5205-15. PubMed ID: 21705006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of UPLC method for determination of primaquine phosphate and its impurities.
    Dongre VG; Karmuse PP; Rao PP; Kumar A
    J Pharm Biomed Anal; 2008 Jan; 46(2):236-42. PubMed ID: 18029132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-benefit evaluation of on-line high-performance liquid chromatography analysis for pooling decisions in large-scale chromatography.
    Kaltenbrunner O; Lu Y; Sharma A; Lawson K; Tressel T
    J Chromatogr A; 2012 Jun; 1241():37-45. PubMed ID: 22560704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why ultra high performance liquid chromatography produces more tailing peaks than high performance liquid chromatography, why it does not matter and how it can be addressed.
    Petersson P; Forssen P; Edström L; Samie F; Tatterton S; Clarke A; Fornstedt T
    J Chromatogr A; 2011 Sep; 1218(39):6914-21. PubMed ID: 21872875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automating method validation and system suitability testing in HPLC and CE.
    Kohn A
    Am Biotechnol Lab; 1994 Oct; 12(11):44. PubMed ID: 7765425
    [No Abstract]   [Full Text] [Related]  

  • 13. Ruggedness and robustness testing.
    Dejaegher B; Heyden YV
    J Chromatogr A; 2007 Jul; 1158(1-2):138-57. PubMed ID: 17379230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
    Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
    J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of new methodologies based on design of experiments, independent component analysis and design space for robust optimization in liquid chromatography.
    Debrus B; Lebrun P; Ceccato A; Caliaro G; Rozet E; Nistor I; Oprean R; Rupérez FJ; Barbas C; Boulanger B; Hubert P
    Anal Chim Acta; 2011 Apr; 691(1-2):33-42. PubMed ID: 21458628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A workflow for column interchangeability in liquid chromatography using modeling software and quality-by-design principles.
    Kormány R; Tamás K; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2017 Nov; 146():220-225. PubMed ID: 28886523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast and efficient size-based separations of polymers using ultra-high-pressure liquid chromatography.
    Uliyanchenko E; Schoenmakers PJ; van der Wal S
    J Chromatogr A; 2011 Mar; 1218(11):1509-18. PubMed ID: 21300362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an UPLC method for determination of content uniformity in low-dose solid drugs products using the design space approach.
    Oliva A; Fariña JB; Llabrés M
    Talanta; 2013 Oct; 115():490-9. PubMed ID: 24054623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design and use of a simple System Suitability Test Mix for generic reverse phase high performance liquid chromatography-mass spectrometry systems and the implications for automated system monitoring using global software tracking.
    Mutton I; Boughtflower B; Taylor N; Brooke D
    J Chromatogr A; 2011 Jun; 1218(23):3711-7. PubMed ID: 21543072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603).
    Gavin PF; Olsen BA
    J Pharm Biomed Anal; 2008 Feb; 46(3):431-41. PubMed ID: 18082352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.